drugset
drugset / Trial / NCT02216461

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS for HandiHaler® in Healthy Male Volunteers

NCT02216461 ↗

Phase 1 Completed 36 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

To investigate safety, tolerability, and pharmacokinetics of BIBW 2948 BS after repeated dosing

Timeline

Start
2006-01
Primary completion
2006-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject BIBW 2948 BS Unknown — Inhaled

Indications

No indication recorded.